Epigenetic modification in Parkinson’s disease
Authors:
Open Access
- 7 June 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1123621
Abstract
Parkinson’s disease (PD) is a common neurodegenerative disorder caused by genetic, epigenetic, and environmental factors. Recent advance in genomics and epigenetics have revealed epigenetic mechanisms in PD. These epigenetic modifications include DNA methylation, post-translational histone modifications, chromatin remodeling, and RNA-based mechanisms, which regulate cellular functions in almost all cells. Epigenetic alterations are involved in multiple aspects of neuronal development and neurodegeneration in PD. In this review, we discuss current understanding of the epigenetic mechanisms that regulate gene expression and neural degeneration and then highlight emerging epigenetic targets and diagnostic and therapeutic biomarkers for treating or preventing PD.Keywords
This publication has 87 references indexed in Scilit:
- Genetics and Epigenetics of Parkinson's DiseaseThe Scientific World Journal, 2012
- Proteasome inhibition induces α-synuclein SUMOylation and aggregate formationJournal of the Neurological Sciences, 2011
- Study of Methylation Levels of Parkin Gene Promoter in Parkinson's Disease PatientsInternational Journal of Neuroscience, 2011
- α-Synuclein Sequesters Dnmt1 from the NucleusJournal of Biological Chemistry, 2011
- The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognitionNature Reviews Molecular Cell Biology, 2010
- Histones: Annotating ChromatinAnnual Review of Genetics, 2009
- Epigenetics in the Nervous System: Figure 1.The Journal of Neuroscience, 2008
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007
- Translated mutation in the Nurr1 gene as a cause for Parkinson's diseaseMovement Disorders, 2006
- DNA methylation patterns and epigenetic memoryGenes & Development, 2002